🇺🇸 Leptin in United States

14 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 27 March 2025 – 27 March 2026
• Total reports: 14

Most-reported reactions

1. Asthenia — 2 reports (14.29%)
2. Drug Ineffective — 2 reports (14.29%)
3. Drug Ineffective For Unapproved Indication — 2 reports (14.29%)
4. Off Label Use — 2 reports (14.29%)
5. Adhesion — 1 report (7.14%)
6. Anaemia — 1 report (7.14%)
7. Angioedema — 1 report (7.14%)
8. Arthralgia — 1 report (7.14%)
9. Cardio-Respiratory Arrest — 1 report (7.14%)
10. Dengue Fever — 1 report (7.14%)

Source database →

Frequently asked questions

Is Leptin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Leptin in United States?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is the originator. The local marketing authorisation holder may differ — check the official source linked above.